BGN and osteosarcoma: As demonstrated in Figure 11 cyclin D1 expression was significantly (p ≤ 0.01) downregulated in biglycan-deficient cells, suggesting that biglycan affects both canonical and non-canonical signaling in osteosarcoma cells.